Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
Transurethral resection of the prostate (TUR-P) has been established as the golden standard for the treatment of urinary retention in patients with benign prostatic hyperplasia (BPH). However, TUR-P is not performed on patients with certain high-risk complications. We have obtained favorable results using urethral stent (Angiomed-Memotherm) implantation to treat high-risk urinary retention patients. Here, we review the results obtained on 15 patients treated using this procedure. Two patients experienced recurrent urinary retention; in one patient, the stent had to be removed due to stone formation; in the remaining 12 patients, urination was favorable after stent implantation. Also, urethral stent implantation was found to be useful in 4 of the 7 patients with neurogenic bladder (rather than BPH) as the underlying disease. The present technique is convenient and noninvasive, and we strongly believe that it can improve the patient's quality of life (QOL) by facilitating urination in high-risk patients who would otherwise require urethral catheterization.
Uchikoba
Takushi
T
The Department of Urology, Nippon Medical School Second Hospital.
Horiuchi
Kazutaka
K
Satoh
Mitsuhiro
M
Oka
Fumiatsu
F
Saitoh
Yuka
Y
Tsuboi
Narumi
N
Nishimura
Taiji
T
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications*; D015607:Stents; D014521:Urethra / Q000601:surgery*; D016055:Urinary Retention / Q000209:etiology* / Q000503:physiopathology / Q000601:surgery*; D014554:Urination